Previous Article | Next Article 
Molecular and Cellular Biology, September 2000, p. 6195-6200, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Immunocytochemical Analyses and Targeted Gene Disruption
of GTPBP1
Satoru
Senju,1
Ken-ichi
Iyama,2
Hironori
Kudo,1
Shinichi
Aizawa,3 and
Yasuharu
Nishimura1,*
Division of Immunogenetics, Kumamoto
University Graduate School of Medical
Sciences,1 and Department of
Surgical Pathology2 and Department of
Morphogenesis, Institute of Molecular Embryology and
Genetics,3 Kumamoto University School of
Medicine, Kumamoto 860, Japan
Received 8 May 2000/Accepted 18 May 2000
 |
ABSTRACT |
We previously identified a gene encoding a putative
GTPase, GTPBP1, which is structurally related
to elongation factor 1
, a key component of protein
biosynthesis machinery. The primary structure of GTPBP1
is highly conserved between human and mouse (97% identical at
the amino acid level). Expression of this gene is
enhanced by gamma interferon in a monocytic cell line, THP-1. Although counterparts of this molecule in Caenorhabditis
elegans and Ascaris suum have also been identified,
the function of this molecule remains to be clarified. In the present
study, our immunohistochemical analyses on mouse tissues revealed that
GTPBP1 is expressed in some neurons and smooth muscle cells
of various organs as well as macrophages. Immunofluorescence analyses
revealed that GTPBP1 is localized exclusively in cytoplasm
and shows a diffuse granular network forming a gradient from
the nucleus to the periphery of the cells in smooth muscle cell lines
and macrophages. To investigate the physiological role of
GTPBP1, we used targeted gene disruption in
embryonic stem cells to generate GTPBP1-deficient
mice. The mutant mice were born at the expected Mendelian frequency,
developed normally, and were fertile. No manifest anatomical or
behavioral abnormality was observed in the mutant mice. Functions of
macrophages, including chemotaxis, phagocytosis, and nitric oxide
production, in mutant mice were equivalent to those seen in wild-type
mice. No significant difference was observed in the immune response to
protein antigen between mutant mice and wild-type mice, suggesting normal function of antigen-presenting cells of the mutant mice. The
absence of an eminent phenotype in GTPBP1-deficient mice may be due to functional compensation by GTPBP2, a molecule we
recently identified which is similar to GTPBP1 in structure
and tissue distribution.
 |
INTRODUCTION |
Gamma interferon (IFN-
) is a key
monocyte-activating cytokine (3, 17, 20, 27). With IFN-
stimulation, the human monocytic cell line THP-1 expresses a number of
genes associated with the antigen-presenting function of macrophages,
including major histocompatibility complex class II (MHC-II), CD74
(MHC-II-associated invariant chain), and interleukin-1
(7, 26; our unpublished observation). To identify
genes involved in the function of macrophages, we had previously
carried out PCR-based cDNA subtraction and subsequent differential
display on mRNA obtained from IFN-
-treated and untreated THP-1
cells. In so doing, we found a novel gene encoding protein bearing
GTP-binding motifs, the characteristic of the
GTPase superfamily, and we designated this gene
GP-1 (22). We later renamed the gene
GTPBP1, as recommended by the Human Gene
Nomenclature Committee.
GTPBP1 is highly conserved between human and mouse (97%
identical over the entire protein). In Northern blot analyses on mouse tissues, transcripts of the gene are evident in various tissues, with a
relatively high expression in brain, thymus, and lung. GTPBP1
is similar to the putative GTPases of nematodes, AGP-1 of
Ascaris suum and CGP-1 of Caenorhabditis elegans
(11). The sequence similarity in total protein between
GTPBP1 of mouse and CGP-1 of C. elegans is about
45%, the amino acid sequences of four GTP-binding motifs (G1
to G4) of them being practically identical. Therefore, we proposed a
novel GTPase subfamily, the GP-1 family, composed of human
and mouse GTPBP1, AGP-1 of A. suum, and CGP-1 of
C. elegans. The primary structure of members of GP-1 family is related to those of elongation factor 1
(eEF-1
) and elongation factor Tu (EF-Tu), key components of protein synthesis machinery in
eukaryotes and prokaryotes, respectively. By a TBLASTN (protein query
versus nucleotide database) search against expressed sequence tag
databases, using the amino acid sequence of mouse
GTPBP1 as a query, we found uncharacterized sequences highly
similar to GTPBP1 in zebra fish (GenBank accession no.
AI436986) and in Drosophila melanogaster (GenBank
accession no. AA949198). They presumably represent members of
this family in the species. On the other hand, sequences closer to
those of GP-1 family than to those of EFs were not evident in
yeast and prokaryotes. Therefore, the members of the GP-1 family
may play some role, probably essential for and unique to multicellular organisms.
We have now done an immunohistochemical analysis on various mouse
organs and immunofluorescence analyses on cultured cells to examine
cellular and subcellular localizations of GTPBP1 protein. In
addition, we developed mice carrying a mutation in the
GTPBP1 gene by using targeted gene disruption.
 |
MATERIALS AND METHODS |
Antibodies.
Polyclonal antibodies recognizing near the amino
terminus (GP1a) and carboxyl terminus (GP1b) of the GTPBP1
protein were raised by immunizing rabbits with keyhole limpet
hemocyanin (KLH)-conjugated synthetic oligomer peptides
CGETIYVIGQGSDGTE and CSGGRRRGGQRHKVKS, respectively. Antibodies were
purified from immune sera, using peptide affinity chromatography, and
specificity was verified by immunoblot analyses and indirect
immunofluorescence analyses on COS-7 cells transfected with a mouse
GTPBP1 expression vector. For preabsorption
experiments, peptides were used in 100-fold molar excesses.
Anti-influenza virus hemagglutinin (HA) monoclonal antibody (clone
12CA5) and phycoerythrin-labeled anti-mouse macrophage antibody (clone
F4/80) were purchased from Boehringer Mannheim and Caltag Laboratories,
respectively. Absence of cross-reaction of fluorescein isothiocyanate
(FITC)-labeled goat anti-mouse immunoglobulin G (IgG) polyclonal
antibody (PharMingen) to rabbit antibody and of Cy-3-labeled goat
anti-rabbit IgG polyclonal antibody (Amersham Pharmacia) to mouse IgG
was confirmed.
Construction of the expression vector.
A mouse
GTPBP1 cDNA clone isolated from a mouse brain cDNA
library (30) was inserted into the mammalian expression
vector pBJ1, downstream of the SR
promoter (25).
Subsequently, double-stranded oligomer DNA coding for the HA epitope
(MYPYDVPDYA) was added just downstream of the initiation codon to
obtain the HA-tagged GTPBP1 expression construct
pSRHAGP1. COS-7 cells were transfected with the construct by
lipofection using Transfectam reagent (Promega). Twenty-four hours
after the transfection, the cells were harvested and reseeded on coverslips.
Immunofluorescence analysis.
Cells cultured overnight on
coverslips coated with fibronectin were washed twice with
phosphate-buffered saline (PBS) and treated with fixative solution (PBS
containing 4% paraformaldehyde) for 15 min at room temperature. After
being washed three times with PBS, cells were treated with ethanol for
2 min, with permeabilizing buffer (PBS containing 0.1% Triton X-100
and 2% bovine serum albumin) for 2 min, and with blocking buffer (PBS
containing 2% bovine serum albumin) for 30 min. The cells were stained
with primary antibodies for 1 h, washed 3 times with PBS, stained
with FITC- or Cy3-labeled secondary antibodies for 1 h, and washed
three times with PBS. A fluorescence microscope (Axioplan 2; Carl
Zeiss) was used for microscopy.
Immunoblot analysis.
Tissues and cultured cells were
homogenized in lysis buffer (1% sodium dodecyl sulfate [SDS],
60 mM Tris-HCl [pH 6.8], 10% glycerol), and then lysates were
subjected to electrophoresis on SDS-polyacrylamide gels, under
reducing conditions, and transferred onto nitrocellulose membranes
(Trans-Blot; Bio-Rad). Membranes were probed with
anti-GTPBP1 antibody and subsequently with
peroxidase-conjugated goat anti-rabbit IgG. Signals were visualized by
chemiluminescence, using ECL reagent (Amersham Pharmacia). In some
analyses, filters were reprobed with antibodies after being treated
with stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM
Tris-HCl, pH 6.7) for 30 min at 60°C and extensively washed with
Tris-buffered saline containing 0.2% Tween.
Immunohistochemical analysis.
Anesthetized female C57BL/6
mice underwent intracardiac perfusion with fixative solution. The
tissues were removed, immersed in fixative solution at 4°C for
16 h, dehydrated, and embedded in paraffin. Sections (6 µm) were
deparaffinated, treated with methanol-H2O2 for
inactivation of endogenous peroxidase activity, and stained with
anti-GTPBP1 antibody, GP1a. As a negative control, nonimmunized rabbit serum was also used in the same experiments. For
immunohistochemical detection, we used the avidin-biotin-peroxidase technique (Vectastain ABC kit; Vector Laboratories, Burlingame, Calif.)
and peroxidase was developed using diaminobenzidene. Immunostained sections were counterstained with methyl green.
Construction of the targeting vector.
A mouse
GTPBP1 cDNA clone was used as a probe to
isolate genomic DNA clones corresponding to the GTPBP1
loci from a mouse genomic DNA library. In the targeting vector,
pKO-GP1, the genomic region encoding amino acids 58 to 193 (in the
previously published amino acid sequence [22]) of
GTPBP1 was replaced with a phosphoglycerate kinase (PGK)-neomycin
phosphotransferase (neoR)-poly(A) cassette. The vector contained
homologous genomic DNA fragments 6.2 and 1.25 kb on either side of the
PGK-neoR cassette. The PGK-thymidine kinase (tk)-poly(A) cassette and
pMC1-diphtheria toxin A (DT)-poly(A) cassette (28) were
ligated on the 3' and 5' ends, respectively.
Generation of GTPBP1-mutant mice.
Culture and
transfection of TT2 (29) embryonic stem (ES) cells were done
as previously described (14, 16, 31). Transfected ES cells
were selected in medium containing G418 (200 µg/ml) and ganciclovir
(2 µM). Drug-resistant ES cell clones were screened by PCR with a
flanking primer (5'-CTTGTCCTGGCATTCCCCTACACT-3') and a
PGK-promoter-specific primer (5'-TGCTAAAGCCCATGCTCCAGACTG-3'), which yields a 1.25-kb product in the case of proper homologous recombination. PCR-positive clones were analyzed by Southern blot analyses to verify homologous recombination. Homologous recombinant ES
cell clones were injected into ICR eight-cell stage embryos, and the
embryos were implanted into the uteri of pseudopregnant ICR mice to
generate chimeric mice. Male chimeras were mated with C57BL/6 female
mice. F1 offspring were genotyped to select heterozygous mutant mice. Heterozygous mutant mice were intercrossed, and homozygous mutant mice were obtained. Genotypes of the mice were routinely determined with tail DNA, using PCR. A mutant allele-specific primer
(5'-GCCTACCCGCTTCCATTGCTCAG-3'), a wild-type-specific primer (5'-GCTAGTTCCTGAGGAGATACTCGA-3'), and a common primer
(5'-ATCCTCTTACGAGAACGTCAAGAAG-3') were mixed in each
reaction mixture, and PCR products about 350 and 500 bp in length
appeared from the mutated and wild-type alleles, respectively. The
results of PCR were occasionally confirmed by Southern blot analyses.
Mice at ages of 8 to 16 weeks were used for the functional analyses.
Isolation of peritoneal macrophages.
Mice were
intraperitoneally injected with 2 ml of 4% Brewer thioglycollate
solution. Four days later, exudating cells were obtained by lavage of
the peritoneal cavity with 6 ml of PBS. The number of cells obtained
from each mouse was determined using a Neubauer hemacytometer. Aliquots
of harvested cells were stained with phycoerythrin-labeled anti-mouse
macrophage antibody (F4/80) and analyzed on a flow cytometer (FACScan;
Becton Dickinson).
Adhesion assay.
Adhesion assays were done as previously
reported (24), with some modification. In brief,
thioglycollate-elicited peritoneal cells suspended in RPMI 1640 medium
supplemented with 10% fetal calf serum were plated at a density of
2 × 105 cells per well in 96-well flat-bottom plates
and incubated for 50 min at 37°C. Cells in plates were fixed in
methanol and stained with 10% Giemsa's solution. Plates were washed
five times with water and dried. Retained dye was solubilized in
methanol and measured as the absorbance at 450 nm on a microplate
reader (model 550; Bio-Rad).
Phagocytosis assay.
Cell suspensions in RPMI 1640 medium
supplemented with 10% fetal calf serum were plated at a density of
106 cells per well in 24-well tissue culture plates and
allowed to adhere to the plates overnight at 37°C. Nonadherent cells
were then removed by washing the plates with RPMI 1640 medium. BODIPY FL-labeled zymosan particles (Molecular Probes) were opsonized with IgG
and added to the plates (107/well). Plates were incubated
for 15 min at 37°C, treated with lyticase (1,000 U/ml) for 5 min, and
washed with PBS. Subsequently, the cells were fixed with fixative
solution for 10 min, harvested, and analyzed using a flow cytometer.
Analysis of immune response to KLH.
Wild-type and homozygous
mutant mice were genotyped by PCR to select mice bearing the
I-Ak/k genotype. Selected mice were immunized at
the base of the tail with 50 µg of KLH protein emulsified in complete
Freund's adjuvant. After 8 days, these mice were killed and bilateral
inguinal and para-aortic lymph nodes were isolated. Single-cell
suspensions were made from lymph nodes in RPMI 1640 medium supplemented
with 10% horse serum. Cells were seeded in 96-well flat-bottom culture plates (4 × 105/well) in the presence or absence of
KLH (10 µg/ml) and cultured for 5 days. [3H]thymidine
(1 µCi/well, 6.7 Ci/mmol) was added to the culture in the last
18 h, and the incorporation of [3H]thymidine was
measured by scintillation counting.
 |
RESULTS |
Subcellular localization of GTPBP1.
To determine the
subcellular localization of GTPBP1, we carried out
indirect immunofluorescence analyses on several types of cultured
cells. COS-7 cells were transiently transfected with an HA-tagged
GTPBP1 expression vector, pSRHAGP1, and grown on fibronectin-coated coverslips. The cells were double stained
with anti-HA monoclonal antibody (12CA5) and anti-GTPBP1
polyclonal antibody (GP1a), and signals were detected using
FITC-labeled anti-mouse IgG antibody and Cy3-labeled anti-rabbit IgG
antibody, respectively (Fig. 1A and B).
As expected, fluorescence signals of the two antibodies showed the same
distribution. No fluorescence signal was observed when GP1a was
preabsorbed by excess amounts of the peptide used to raise the antibody
or when mock-transfected COS-7 cells were stained (not shown). Forced
expression of GTPBP1 led to no change in the morphology of
the cells and structures of actin filaments and microtubules in COS-7
cells (not shown). The rat aortic smooth muscle cell line, A-10
(13), and mouse peritoneal macrophages elicited by
stimulation with thioglycollate solution, both of which express
abundant intrinsic GTPBP1 protein, were also stained with
GP1a (Fig. 1C and D). In all of these cells, GTPBP1 is
present exclusively in the cytoplasm, and punctate or irregular
distribution with much of the signal in the juxtanuclear region was
observed. The distribution in A-10 cells and in macrophages appeared as
finer granules than those seen in COS cell transfectants. The forced
expression of the molecule or addition of the HA tag sequence at the
amino terminus of the molecule may affect intracellular distribution in
the transfectants. The expression of GTPBP1 was observed in
another rat aortic cell line, A7r5 (13), and mouse L cells,
and staining patterns were similar to those observed in A-10 cells and
macrophages (not shown). Absence of specific fluorescence in the
nucleus was also confirmed by confocal microscopic analyses (not
shown). In some cells, GTPBP1 was also enriched in a region
adjacent to the plasma membrane in podosomes and in cell edges.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Immunofluorescence analysis of cultured cells
on the intracellular distribution of GTPBP1. COS-7 cells were
transfected with an HA-tagged mouse GTPBP-1 expression
vector, pSRHAGP1, and cultured on coverslips. Forty-eight hours
after the transfection, cells were double stained with anti-HA
monoclonal antibody (12CA5) and anti-GTPBP1 polyclonal
antibody (GP1a). Staining signals with 12CA5 were visualized by
FITC-labeled anti-mouse IgG (A), and the GP1a staining signal was
visualized by Cy3-labeled anti-rabbit IgG (B). A rat aortic smooth
muscle cell line, A10 (C), and mouse peritoneal macrophages (D) were
also cultured on coverslips and stained with GP1a. Magnifications,
×850 (A, B, and C) and ×340 (D).
|
|
Tissue distribution of GTPBP1 protein in various mouse
tissues.
To determine the distribution of GTPBP1
molecule in tissues, we analyzed various organs of C57BL/6 mice by
immunohistochemistry. Paraffin-embedded tissue sections were
stained with the anti-GTPBP1 polyclonal antibody, GP1a.
Figure 2A shows a section of the cerebral cortex. GTPBP1 is expressed in some neurons but not in
neuroglia cells. In the thymus, GTPBP1 is found in small
arteries as well as in macrophages and dendritic cells in the medulla,
but not in thymocytes (Fig. 2B). In the lung, GTPBP1 is
expressed in bronchi (Fig. 2C) and pulmonary arteries (Fig. 2D).
GTPBP1 is expressed in bronchial epithelial cells and
submucosal smooth muscle cells. In pulmonary arteries, smooth muscle
cells of tunica media are stained. Table
1 summarizes the results of
immunohistochemical analyses on various mouse organs. In addition to
neurons and macrophages, GTPBP1 is expressed in smooth muscle
cells in a broad range of organs, for example, blood vessels,
respiratory and digestive tracts, uterus, and urinary bladder.

View larger version (134K):
[in this window]
[in a new window]
|
FIG. 2.
Immunohistochemical localization of GTPBP1 in
several mouse organs. Expression of GTPBP1 is seen in some
neurons in the cerebral cortex (A), arterial smooth muscle cells and
macrophages in thymus (B), bronchial epithelial cells and peribronchial
smooth muscle cells (C), and smooth muscle cells of the pulmonary
artery (D). Magnifications, ×200.
|
|
Generation of GTPBP1-mutant mice.
To
assess the physiological role of GTPBP1, we developed mutant
mice devoid of normal GTPBP1 protein. The targeting vector, pKO-GP1, was made so as to yield, by homologous recombination, a mutant
allele in which the genomic region coding for most of the putative
GTP-binding domain (22) of GTPBP1 was
replaced by a neomycin resistance gene cassette (Fig.
3A). The targeting vector was transfected
into TT2 (29) ES cells, and cells were then cultured in
selection medium containing G418 and ganciclovir. Two homologous
recombinant ES cell clones were obtained out of 540 double-resistant ES
clones analyzed. Cells from the two ES clones were injected into
eight-cell stage embryos of ICR mice. One ES cell clone gave rise to a
germ line-transmitted mutant mouse strain.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 3.
Generation of GTPBP1-mutant mice.
(A) Schematic depiction of a part of the mouse
GTPBP1 gene, the targeting vector, and the mutant
allele. Closed boxes indicate two exons coding for amino acids 17 to 77 and 78 to 193 (according to a previously published amino acid sequence
[22]) of the GTPBP1 protein, respectively.
The targeting vector contains a neomycin resistance gene (pgkNeo-R) for
positive selection and the diphtheria toxin A gene (MC1DT) and
herpesvirus thymidine kinase gene (pgkTK) for negative selection. (B)
Southern blot analysis showing homologous recombination. Genomic DNA
samples from a wild-type mouse, a hemizygous mutant mouse, and a
homozygous mutant mouse were digested with EcoRI and
EcoRV. The location of the probe, a 0.6-kb
HindIII-HindIII genomic DNA fragment used
for Southern blot analyses, is shown in panel A. The 7.5-kb band
indicates the wild type, and the 6.0-kb band indicates the mutant
allele shown in panel A. (C and D) Immunoblot analyses showing the
absence of an intact GTPBP1 molecule in a homozygous mutant
mouse. Lysates of brain were made from a wild type and a homozygous
mutant mouse, electrophoresed in an SDS-polyacrylamide gel, transferred
onto a nitrocellulose membrane, and probed with polyclonal antibodies
GP1a (C) and GP1b (D), which recognize amino- and carboxyl-terminal
portions of the GTPBP1 protein, respectively.
|
|
The hemizygous mutant female and male mice were crossed to examine the
phenotype caused by GTPBP1 deficiency. Among the
304 offspring analyzed, 75 were homozygous mutant mice (35 males and 40 females), as expected from Mendelian transmission. Figure 3B shows an
example of a Southern blot analysis of the GTPBP1
locus of a wild-type, hemizygous mutant and homozygous mutant mice. To
confirm that the homozygous mutant mice lacked intact GTPBP1 protein, we examined lysates made from brain of wild-type and homozygous mutant mice by immunoblot analysis, using polyclonal antibodies GP1a and GP1b recognizing amino- and carboxyl-terminal portions of the protein, respectively (Fig. 3C).
The homozygous mutant mice were apparently normal; the external
appearances of the whole body and each organ were
indistinguishable from those of wild-type mice. Mutant mice had
no overt neurological and behavioral deficits; they grew up
normally and were healthy at least up to the age that we have
studied them (12 months). Both male and female homozygous mutant
mice yielded offspring normally. In addition, no abnormality was
found in histological analyses of organs in which GTPBP1 is
expressed, i.e., brain, thymus, lung, spleen, and kidney.
Function of GTPBP1-deficient
macrophages.
The expression of GTPBP1 is enhanced by
IFN-
in THP-1 cells, accompanying the expression of genes
related to functions of macrophages, and this molecule is
abundantly expressed in peritoneal macrophages elicited by stimulation
with thioglycollate. Therefore, we assumed that GTPBP1 may be
involved in some functions of macrophages. Although the homozygous
mutant mice appeared healthy under specific-pathogen-free conditions in
our mouse facility, we reasoned that homozygous GTPBP1-deficient mice may bear some deficits
in the immune system.
We analyzed several macrophage functions, comparing
thioglycollate-elicited peritoneal macrophages obtained from wild-type and mutant mice. We assessed the chemotactic activity of macrophages by
counting the number of peritoneally exudating macrophages defined by
staining with monoclonal antibody F4/80 (Fig.
4A). Four days after the intraperitoneal
injection of thioglycollate solution, almost the same numbers of
macrophages were recovered by lavage of the peritoneal cavity of the
wild-type and homozygous mutant mice. We analyzed the adhesional
activity of the peritoneal macrophages, using the Giemsa
assay. As shown in Fig. 4B, peritoneally exudating cells of wild-type
and mutant mice adhered to the surface of culture plates at almost the
same rate. Morphologies of the adhering cells were indistinguishable
between macrophages obtained from wild-type and mutant mice. To
investigate the possibility that GTPBP1 is involved in
phagocytic activity, we analyzed Fc-receptor-mediated phagocytosis of
IgG-opsonized zymozan particles. Peritoneal macrophages were incubated
with fluorescent zymozan particles coated with mouse IgG, and numbers
of macrophages which ingested zymozan particles were examined by flow
cytometric analysis (Fig. 4C). The phagocytic activity of macrophages
from wild-type and mutant mice were also equivalent in this analysis.
Other than these analyses, we examined macrophages regarding expression
of MHC-II molecules and Fc
-receptor (CD16/32), phagocytosis of
polystyrene beads, and nitric oxide production under the stimulation of
IFN-
and lipopolysaccharides. However, we found no differences
between wild-type and mutant mice.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Macrophage function and immune response of
GTPBP1 mutant mice. (A) Mice were intraperitoneally injected
with Brewer thioglycollate solution. Four days later, the number of
macrophages in the peritoneal cavity of each mouse was counted. Mean
values + SD for three wild-type and seven mutant mice are shown.
(B) Adhesional activity of peritoneal macrophages to tissue
culture-treated plastic surfaces. Cells were plated into 96-well
culture plates, incubated for 50 min at 37°C, stained with 10%
Giemsa's solution, and extensively washed. Retained dye was measured
as the absorbance at 450 nm on a microplate reader. Mean values + SD for five wild-type and nine mutant mice are shown. (C) Phagocytic
activity of peritoneal macrophages. Peritoneal macrophages were
incubated with BODIPY FL-labeled zymosan particles coated with IgG in
culture plates for 15 min, fixed with formaldehyde, harvested, and
analyzed on a flow cytometer. Percentages of macrophages with high
fluorescence were shown. Values are means + SD for three wild-type
and seven mutant mice. (D) Immune response to KLH. Mice were
subcutaneously immunized at the base of the tail with 50 µg of KLH
emulsified in complete Freund's adjuvant. Eight days after the
immunization, single-cell suspensions were made from draining lymph
nodes. Lymph node cells were cultured for 5 days with KLH (10 µg/ml) in 96-well plates. The proliferative response in the last
18 h of the culture were measured by [3H]thymidine
uptake and mean values + SD for seven wild-type and five mutant
mice are shown. For both wild-type and mutant mice, counts were less
than 2,000 cpm in the case of lymph node cells that were cultured in
the absence of the antigen.
|
|
Immune response to protein antigen of
GTPBP1-mutant mice.
It has been established
that dendritic cells are the most potent antigen-presenting cells
responsible for stimulating T lymphocytes in peripheral lymphoid
organs. It was reported that monocyte-derived dendritic cells play a
major role in transportation of antigens from peripheral tissues to
draining lymph nodes in vivo (19). We found by reverse
transcription-PCR analyses that GTPBP1 is expressed
also in myeloid-lineage dendritic cells differentiated in vitro (data
not shown). Therefore, it may be that the absence of normal functions
of GTPBP1 in dendritic cells would elicit deficient T-cell
responses to antigenic challenge. We analyzed the immune
response to protein antigen of GTPBP1-mutant
mice. Because immune response to exogenous protein antigen is affected by allotype in the MHC-II locus, mice of the
I-Ak/k genotype were selected from wild-type and
homozygous mutant mice and used for this experiment. Eight days after
immunization with KLH to the base of the tail, almost the same numbers
of the cells were obtained from inguinal and para-aortic lymph nodes of
wild-type and mutant mice ([4.5 ± 1.4] × 107 and
[3.3 ± 1.7] × 107 [mean ± standard
deviation {SD}] per mouse, respectively). To analyze the
reactivity of antigen-specific T cells and function of
antigen-presenting cells, isolated lymph node cells were cultured in
vitro in the absence or presence of KLH and the proliferative response
was determined according to [3H]thymidine
incorporation. As shown in Fig. 4D, lymph node cells from wild-type and
mutant mice showed almost the same proliferative response when cultured
in vitro with KLH, thereby indicating that functions of
antigen-presenting cells were not affected by GTPBP1 deficiency.
 |
DISCUSSION |
Among the GTPase superfamily, the primary structure of
the GP-1 family is closest to that of G proteins involved in protein translational machinery, such as initiation factors, EF-1
, EF-Tu, and GST1/RF3 (10). These G proteins play essential roles in initiation, elongation, and termination of protein translation in both
prokaryotes and eukaryotes. The indirect immunofluorescence analyses in
the present study revealed that the GTPBP1 molecule is
localized exclusively in the cytoplasm as a diffuse granular network
pattern with highly immunofluorescent signals in a perinuclear region.
The localization pattern is similar to the reported localization of
components of protein synthesis machinery (21), suggesting that GTPBP1 colocalizes with these molecules and functions in related protein synthesis machinery. To elucidate this issue, double
immunostaining analyses with antibodies specific to ribosomal protein
would be necessary.
Because of the evolutionary conservation of GTPBP1, we
presumed that the homozygous mutant mice would show some abnormality. However, we found no gross morphological and behavioral abnormalities of the mutant mice. Our analysis showed that
GTPBP1 is not essential for general functions of
macrophages, such as chemotaxis, plastic-surface adhesion,
phagocytosis, and production of nitric oxide. The development of T
lymphocytes, which is potentially influenced by cells of macrophage
lineage, of the mutant mice appeared normal in the flow cytometric
analyses (data not shown). Proliferative response of T lymphocytes to
antigenic challenge with protein antigen was also normal, indicating
that antigen processing and presentation by macrophages and dendritic
cells were not affected by the mutation of GTPBP1.
In mammals, IFN-
, along with IFN-
and IFN-
, plays a key role
in the host defense against pathogenic microorganisms. The activation
of macrophages by IFN-
is essential for resistance to intracellular
bacterial infections, such as listeriosis and tuberculosis (2, 6,
12). In addition to activating macrophages, these cytokines
affect a variety of cell types and induce expression of
genes essential for host defense (5, 9). The MX proteins (1, 23), GTPases induced by IFN-
and -
, are
involved in resistance to several types of viruses. Although
GTPBP1-deficient mice seemed healthy under
pathogen-free conditions, IFN-
-inducible expression of
GTPBP1 raises the possibility that GTPBP1 is
involved in host defense to a specific pathogen.
In our immunohistochemical analyses, we found that
GTPBP1 is expressed in smooth muscle cells of various tissues
and some neurons in the cerebral cortex as well as in macrophages
(Table 1). The GTPBP1-deficient mice may have a
functional abnormality in these tissues, albeit not evident in
nonstressed situations. As mutant mice seemed more active and
aggressive than wild-type littermates, we conducted several experiments
to examine activity and aggression of these mice. However, we found no
significant difference between mutant and wild type in resident
intruder test (4, 8, 32) and forced swimming test
(18).
A large number of mutant mice have been generated by gene targeting in
ES cells, and their phenotypes are sometimes much more limited than
expected. However, the absence of overt abnormality in mutant mice does
not mean that the genes have no physiological function. There is the
possibility that the absence of apparent defects in mutant mice may be
due to genetic redundancy, i.e., other molecules with similar function
and tissue distribution compensate for the defect of the function of
the gene in those targeting mice. Recently, we identified cDNA of
another member of the GP-1 family, GTPBP2, from a
cDNA library of human macrophages and mouse brain (15).
Mouse GTPBP2 protein bears the GTP-binding motif
similar to those of members of the GP-1 family and shares 44%
similarity with mouse GTPBP1 over the entire amino acid
sequence. The tissue distribution of the GTPBP2 mostly
overlaps that of GTPBP1. It is possible that GTPBP2
compensates for defects in functions of GTPBP1 in the
GTPBP1-mutant mice. The mouse
GTPBP1 and GTPBP2 genes are
located in different chromosomal loci, and generation of
GTPBP2-deficient mice is under way. To assess the possibility
of functional redundancy between GTPBP1 and
GTPBP2, we will develop double-knockout mice which
have defects in both the GTPBP1 and
GTPBP2 loci.
 |
ACKNOWLEDGMENTS |
We are grateful to S. Matsushita, A. Irie, Y. Yasunami, H. Ohkubo, M. Takeya, and H. Nishiura for valuable suggestions. M. Ohara
provided helpful comments on the manuscript.
This work was supported in part by grant-in-aid 10770142 from the
Ministry of Education, Science, Sports, and Culture of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Immunogenetics, Department of Neuroscience and Immunology, Kumamoto
University Graduate School of Medical Sciences, 2-2-1 Honjo, Kumamoto
860-0811, Japan. Phone: 81-96-373-5310. Fax: 81-96-373-5314. E-mail:
mxnishim{at}gpo.kumamoto-u.ac.jp.
 |
REFERENCES |
| 1.
|
Aebi, M.,
J. Fah,
N. Hurt,
C. E. Samuel,
D. Thomis,
L. Bazzigher,
J. Pavlovic,
O. Haller, and P. Staeheli.
1989.
cDNA structures and regulation of two interferon-induced human Mx proteins.
Mol. Cell. Biol.
9:5062-5072[Abstract/Free Full Text].
|
| 2.
|
Buchmeier, N. A., and R. D. Schreiber.
1985.
Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.
Proc. Natl. Acad. Sci. USA
82:7404-7408[Abstract/Free Full Text].
|
| 3.
|
Cofano, F.,
P. M. Comoglio,
S. Landolfo, and G. Tarone.
1984.
Mouse immune interferon enhances fibronectin production of elicited macrophages.
J. Immunol.
133:3102-3106[Abstract].
|
| 4.
|
De Felipe, C.,
J. F. Herrero,
J. A. O'Brien,
J. A. Palmer,
C. A. Doyle,
A. J. Smith,
J. M. Laird,
C. Belmonte,
F. Cervero, and S. P. Hunt.
1998.
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P.
Nature
392:394-397[CrossRef][Medline].
|
| 5.
|
Farrar, M. A., and R. D. Schreiber.
1993.
The molecular cell biology of interferon-gamma and its receptor.
Annu. Rev. Immunol.
11:571-611[CrossRef][Medline].
|
| 6.
|
Flesch, I., and S. H. Kaufmann.
1987.
Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.
J. Immunol.
138:4408-4413[Abstract].
|
| 7.
|
Gaffney, E. V.,
S. E. Lingenfelter,
G. A. Koch,
P. J. Lisi,
C. W. Chu, and S. C. Tsai.
1988.
Regulation by interferon gamma of function in the acute monocytic leukemia cell line, THP-1.
J. Leukoc. Biol.
43:248-255[Abstract].
|
| 8.
|
Hilakivi-Clarke, L. A.,
K. M. Wozniak,
M. J. Durcan, and M. Linnoila.
1990.
Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression.
Physiol. Behav.
48:429-433[CrossRef][Medline].
|
| 9.
|
Hisamatsu, H.,
N. Shimbara,
Y. Saito,
P. Kristensen,
K. B. Hendil,
T. Fujiwara,
E. Takahashi,
N. Tanahashi,
T. Tamura,
A. Ichihara, and K. Tanaka.
1996.
Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma.
J. Exp. Med.
183:1807-1816[Abstract/Free Full Text].
|
| 10.
|
Hoshino, S.,
H. Miyazawa,
T. Enomoto,
F. Hanaoka,
Y. Kikuchi,
A. Kikuchi, and M. Ui.
1989.
A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells.
EMBO J.
8:3807-3814[Medline].
|
| 11.
|
Huang, Y. J.,
R. Stoffel,
H. Tobler, and F. Mueller.
1996.
A newly formed telomere in Ascaris suum does not exert a telomere position effect on a nearby gene.
Mol. Cell. Biol.
16:130-134[Abstract].
|
| 12.
|
Kiderlen, A. F.,
S. H. Kaufmann, and M. L. Lohmann-Matthes.
1984.
Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.
Eur. J. Immunol.
14:964-967[Medline].
|
| 13.
|
Kimes, B. W., and B. L. Brandt.
1976.
Characterization of two putative smooth muscle cell lines from rat thoracic aorta.
Exp. Cell Res.
98:349-366[CrossRef][Medline].
|
| 14.
|
Kohmura, N.,
T. Yagi,
Y. Tomooka,
M. Oyanagi,
R. Kominami,
N. Takeda,
J. Chiba,
Y. Ikawa, and S. Aizawa.
1994.
A novel nonreceptor tyrosine kinase, Srm: cloning and targeted disruption.
Mol. Cell. Biol.
14:6915-6925[Abstract/Free Full Text].
|
| 15.
|
Kudo, H.,
S. Senju,
H. Mitsuya, and Y. Nishimura.
2000.
Mouse and human GTPBP2, newly identified members of the GP-1 family of GTPase.
Biochem. Biophys. Res. Commun.
272:456-465[CrossRef][Medline].
|
| 16.
|
Matsuo, I.,
S. Kuratani,
C. Kimura,
N. Takeda, and S. Aizawa.
1995.
Mouse Otx2 functions in the formation and patterning of rostral head.
Genes Dev.
9:2646-2658[Abstract/Free Full Text].
|
| 17.
|
Murray, H. W.,
B. Y. Rubin, and C. D. Rothermel.
1983.
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
J. Clin. Investig.
72:1506-1510.
|
| 18.
|
Porsolt, R. D.,
M. Le Pichon, and M. Jalfre.
1977.
Depression: a new animal model sensitive to antidepressant treatments.
Nature
266:730-732[CrossRef][Medline].
|
| 19.
|
Randolph, G. J.,
S. Beaulieu,
S. Lebecque,
R. M. Steinman, and W. A. Muller.
1998.
Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking.
Science
282:480-483[Abstract/Free Full Text].
|
| 20.
|
Rollag, H.,
M. Degre, and G. Sonnenfeld.
1984.
Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages.
Scand. J. Immunol.
20:149-155[CrossRef][Medline].
|
| 21.
|
Sanders, J.,
M. Brandsma,
G. M. Janssen,
J. Dijk, and W. Moller.
1996.
Immunofluorescence studies of human fibroblasts demonstrate the presence of the complex of elongation factor-1 beta gamma delta in the endoplasmic reticulum.
J. Cell Sci.
109:1113-1117[Abstract].
|
| 22.
|
Senju, S., and Y. Nishimura.
1997.
Identification of human and mouse GP-1, a putative member of a novel G-protein family.
Biochem. Biophys. Res. Commun.
231:360-364[CrossRef][Medline].
|
| 23.
|
Staeheli, P., and O. Haller.
1985.
Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice.
Mol. Cell. Biol.
5:2150-2153[Abstract/Free Full Text].
|
| 24.
|
Suzuki, H.,
Y. Kurihara,
M. Takeya,
N. Kamada,
M. Kataoka,
K. Jishage,
O. Ueda,
H. Sakaguchi,
T. Higashi,
T. Suzuki,
Y. Takashima,
Y. Kawabe,
O. Cynshi,
Y. Wada,
M. Honda,
H. Kurihara,
H. Aburatani,
T. Doi,
A. Matsumoto,
S. Azuma,
T. Noda,
Y. Toyoda,
H. Itakura,
Y. Yazaki,
T. Kodama, et al.
1997.
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection.
Nature
386:292-296[CrossRef][Medline].
|
| 25.
|
Takebe, Y.,
M. Seiki,
J. Fujisawa,
P. Hoy,
K. Yokota,
K. Arai,
M. Yoshida, and N. Arai.
1988.
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.
Mol. Cell. Biol.
8:466-472[Abstract/Free Full Text].
|
| 26.
|
Virelizier, J. L.,
N. Perez,
F. Arenzana-Seisdedos, and R. Devos.
1984.
Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines.
Eur. J. Immunol.
14:106-108[Medline].
|
| 27.
|
Vogel, S. N.,
D. S. Finbloom,
K. E. English,
D. L. Rosenstreich, and S. G. Langreth.
1983.
Interferon-induced enhancement of macrophage Fc receptor expression: beta-interferon treatment of C3H/HeJ macrophages results in increased numbers and density of Fc receptors.
J. Immunol.
130:1210-1214[Abstract].
|
| 28.
|
Yagi, T.,
S. Nada,
N. Watanabe,
H. Tamemoto,
N. Kohmura,
Y. Ikawa, and S. Aizawa.
1993.
A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene.
Anal. Biochem.
214:77-86[CrossRef][Medline].
|
| 29.
|
Yagi, T.,
T. Tokunaga,
Y. Furuta,
S. Nada,
M. Yoshida,
T. Tsukada,
Y. Saga,
N. Takeda,
Y. Ikawa, and S. Aizawa.
1993.
A novel ES cell line, TT2, with high germline-differentiating potency.
Anal. Biochem.
214:70-76[CrossRef][Medline].
|
| 30.
|
Yasunami, M.,
K. Suzuki,
T. Houtani,
T. Sugimoto, and H. Ohkubo.
1995.
Molecular characterization of cDNA encoding a novel protein related to transcriptional enhancer factor-1 from neural precursor cells.
J. Biol. Chem.
270:18649-18654[Abstract/Free Full Text].
|
| 31.
|
Yoshida, M.,
Y. Suda,
I. Matsuo,
N. Miyamoto,
N. Takeda,
S. Kuratani, and S. Aizawa.
1997.
Emx1 and Emx2 functions in development of dorsal telencephalon.
Development
124:101-111[Abstract].
|
| 32.
|
Yoshimura, H.,
K. Watanabe, and N. Ogawa.
1988.
Psychotropic effects of ginseng saponins on agonistic behavior between resident and intruder mice.
Eur. J. Pharmacol.
146:291-297[CrossRef][Medline].
|
Molecular and Cellular Biology, September 2000, p. 6195-6200, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Motomura, Y., Senju, S., Nakatsura, T., Matsuyoshi, H., Hirata, S., Monji, M., Komori, H., Fukuma, D., Baba, H., Nishimura, Y.
(2006). Embryonic Stem Cell-Derived Dendritic Cells Expressing Glypican-3, a Recently Identified Oncofetal Antigen, Induce Protective Immunity against Highly Metastatic Mouse Melanoma, B16-F10. Cancer Res.
66: 2414-2422
[Abstract]
[Full Text]
-
Greene, J. C., Whitworth, A. J., Andrews, L. A., Parker, T. J., Pallanck, L. J.
(2005). Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum Mol Genet
14: 799-811
[Abstract]
[Full Text]
-
Hirata, S., Senju, S., Matsuyoshi, H., Fukuma, D., Uemura, Y., Nishimura, Y.
(2005). Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand. J. Immunol.
174: 1888-1897
[Abstract]
[Full Text]
-
Monji, M., Nakatsura, T., Senju, S., Yoshitake, Y., Sawatsubashi, M., Shinohara, M., Kageshita, T., Ono, T., Inokuchi, A., Nishimura, Y.
(2004). Identification of a Novel Human Cancer/Testis Antigen, KM-HN-1, Recognized by Cellular and Humoral Immune Responses. Clin. Cancer Res.
10: 6047-6057
[Abstract]
[Full Text]
-
Matsuyoshi, H., Senju, S., Hirata, S., Yoshitake, Y., Uemura, Y., Nishimura, Y.
(2004). Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination. J. Immunol.
172: 776-786
[Abstract]
[Full Text]
-
Senju, S., Hirata, S., Matsuyoshi, H., Masuda, M., Uemura, Y., Araki, K., Yamamura, K.-i., Nishimura, Y.
(2003). Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells. Blood
101: 3501-3508
[Abstract]
[Full Text]